NDRG1 and prostate carcinoma: Both the present investigation examining PC cells and our previous studies using prostate cancer and colon cancer cells (13) also demonstrated that NDRG1 expression inhibited β-catenin phosphorylation at Ser552 promoting its transcriptional activity (46).